Opportunity
SAM #75N98026Q00815AGILENT
NIH NIDDK HPLC-MS System Maintenance and Service Agreement Renewal
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
July 16, 2026
Respond By
July 25, 2026
Identifier
75N98026Q00815AGILENT
NAICS
811210
The National Institutes of Health (NIH), specifically the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is seeking to renew a maintenance and service agreement for its High-Performance Liquid Chromatography–Mass Spectrometry (HPLC-MS) system. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Logistics and Operations (OLAO), Office of Acquisition and Logistics Management (OALM), Hospital and Laboratory Support Division - OEM Highlight: - Agilent Technologies is the referenced Original Equipment Manufacturer (OEM) for the HPLC-MS system - Products/Services Requested: - Maintenance and service agreement renewal for a Liquid Chromatography–Mass Spectrometry (HPLC-MS) system - No specific part numbers or quantities are provided - Notable Requirements: - Service is critical for ongoing research in the Natural Products Chemistry Section of the Laboratory of Bioorganic Chemistry - Supports identification and characterization of synthetic and natural compounds - Procurement is for electronic and precision equipment repair and maintenance (NAICS 811210) - Estimated contract value does not exceed $250,000
Description
Background Information: The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases, to improve people’s health and quality of life.
The Natural Products Chemistry Section of the Laboratory of Bioorganic Chemistry (LBC) conducts research focused on the discovery and development of novel antibiotics and antiviral compounds. Many of these molecules have the potential to become therapeutic agents that could significantly improve human health and support the mission of NIDDK. The laboratory routinely relies on an existing High-Performance Liquid Chromatography–Mass Spectrometry (HPLC-MS) system to identify, characterize, and confirm the structures of synthetic and natural compounds. The HPLC-MS system provides critical data for structural elucidation, molecular composition determination, rapid identification of known compounds, and compound characterization. Continued operation of this analytical system is essential to support ongoing research activities and the generation of data required for publication in peer-reviewed chemistry journals.